Physician profile
Fannie Li
NPI 1386282424
$1,014.50
in general payments reported to CMS, 2019-2025
9 companies · $464 in 2025
The $464 reported for 2025 was more than what 79% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $550 · 2025: $464.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,015.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,014.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $246.17 | 2024-2025 | Gamma, Variax |
| Guard Medical INC. | $158.84 | 2024-2025 | Npseal Large, Npseal |
| Suvon Surgical LLC | $146.43 | 2025 | |
| Depuy Synthes Sales INC. | $136.90 | 2024 | Na |
| Vertex Pharmaceuticals Incorporated | $113.93 | 2024-2025 | |
| Acumed LLC | $82.82 | 2025 | Acumed, Osteomed |
| Kerecis Limited | $69.19 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Ardelyx, INC. | $31.87 | 2025 | Ibsrela |
| Orthofix Medical, INC. | $28.35 | 2025 | Physio-Stim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fannie Li listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.